However, data from the cohort of the present study showed that using parenchymal tumor‐infiltrating CD8+ T‐cell density in the invading tumor edge and peritumoral stroma for predicting cancer recurrence and survival in patients with OSCC was superior to and independent of the cTNM or pTNM staging system. Here, CD8A is linked to cancer.